Why Pfizer's About to Sell 500 Million COVID Vaccine Doses Without Making a Dime
Pfizer (NYSE: PFE) stated in May that it expected its COVID-19 vaccine will generate sales totaling close to $26 billion this year. However, that amount was based on supply agreements in place at the time.
Since then, Pfizer and its partner BioNTech (NASDAQ: BNTX) have landed additional supply deals. The biggest of these was announced only a few days ago. But this major agreement won't be profitable for Pfizer. Here's why it is about to sell 500 million doses of its COVID vaccine without making a dime.
Image source: Getty Images.
Source Fool.com
